This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Rule
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Comments are no longer being accepted.
See DATES for details.
Regulations.gov Data
Enhanced Content - Regulations.gov Data
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
MCAI-2026-00003-Q; B/E AEROSPACE FISCHER GmbH Medical Seat 230/305; ATA 25 – Equipment / Furnishings – Medical Seats – Modification
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
452
as of
11/11/2026 at 6:15 am EST
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2026-08003 as it appeared on Public Inspection on
04/23/2026 at 8:45 am.
It was viewed
26
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2026-08003 (91 FR 21942)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Federal Aviation Administration (FAA), DOT.
ACTION:
Final rule; request for comments.
SUMMARY:
The FAA is adopting a new airworthiness directive (AD) for certain B/E Aerospace Fischer GmbH (B/E Aerospace Fischer) Medical Seats 230/305. This AD was prompted by a determination that certain medical seats that are certified for aft facing (AF) and forward facing (FF) installations have been delivered with an incorrect version of the swivel unit. This AD requires modification and reidentification of the affected medical seats. The FAA is issuing this AD to address the unsafe condition on these products.
DATES:
This AD is effective May 11, 2026.
The Director of the Federal Register approved the incorporation by reference of a certain publication listed in this AD as of May 11, 2026.
The FAA must receive comments on this AD by June 8, 2026.
ADDRESSES:
You may send comments, using the procedures found in 14 CFR 11.43 and 11.45, by any of the following methods:
Federal eRulemaking Portal:
Go to
regulations.gov.
Follow the instructions for submitting comments.
Fax:
(202) 493-2251.
Mail:
U.S. Department of Transportation, Docket Operations, M-30, West Building Ground Floor, Room W12-140, 1200 New Jersey Avenue SE, Washington, DC 20590.
Hand Delivery:
Deliver to Mail address above between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays.
( printed page 21943)
AD Docket:
You may examine the AD docket at
regulations.gov
under Docket No. FAA-2026-3861; or in person at Docket Operations between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. The AD docket contains this final rule, the mandatory continuing airworthiness information (MCAI) any comments received, and other information. The street address for Docket Operations is listed above.
Material Incorporated by Reference:
For Collins Aerospace material identified in this AD, contact Collins Aerospace at B/E Aerospace Fischer GmbH Engineering | Helicopter Seating, Mueller-Armack-Str. 4, 84034 Landshut, Germany; phone: +49 871 932 480; email:info.fischer@collins.com;
website:
collinsaerospace.com.
You may view this material at the FAA, Airworthiness Products Section, Operational Safety Branch, 10101 Hillwood Parkway, Fort Worth, TX 76177. For information on the availability of this material at the FAA, call (817) 222-5110. It is also available atregulations.gov
under Docket No. FAA-2026-3861.
FOR FURTHER INFORMATION CONTACT:
Brenda Buitrago Perez, Aviation Safety Engineer, FAA, 1600 Stewart Avenue, Suite 410, Westbury, NY 11590; phone: (516) 228-7368; email:
9-AVS-AIR-BACO-COS@faa.gov.
SUPPLEMENTARY INFORMATION:
Comments Invited
The FAA invites you to send any written data, views, or arguments about this final rule. Send your comments using a method listed under
ADDRESSES
. Include “Docket No. FAA-2026-3861; Project Identifier MCAI-2026-00003-Q” at the beginning of your comments. The most helpful comments reference a specific portion of the final rule, explain the reason for any recommended change, and include supporting data. The FAA will consider all comments received by the closing date and may amend this final rule because of those comments.
Except for Confidential Business Information (CBI) as described in the following paragraph, and other information as described in 14 CFR 11.35, the FAA will post all comments received, without change, to
regulations.gov,
including any personal information you provide. The agency will also post a report summarizing each substantive verbal contact received about this final rule.
Confidential Business Information
CBI is commercial or financial information that is both customarily and actually treated as private by its owner. Under the Freedom of Information Act (FOIA) (5 U.S.C. 552), CBI is exempt from public disclosure. If your comments responsive to this AD contain commercial or financial information that is customarily treated as private, that you actually treat as private, and that is relevant or responsive to this AD, it is important that you clearly designate the submitted comments as CBI. Please mark each page of your submission containing CBI as “PROPIN.” The FAA will treat such marked submissions as confidential under the FOIA, and they will not be placed in the public docket of this AD. Submissions containing CBI should be sent to Brenda Buitrago Perez, Aviation Safety Engineer, FAA, 1600 Stewart Avenue, Suite 410, Westbury, NY 11590. Any commentary that the FAA receives which is not specifically designated as CBI will be placed in the public docket for this rulemaking.
Background
The European Union Aviation Safety Agency (EASA), which is the Technical Agent for the Member States of the European Union, has issued EASA AD 2025-0294R1, dated February 9, 2026 (EASA AD 2025-0294R1) (also referred to as the MCAI), to correct an unsafe condition on B/E Aerospace Fischer Medical Seat 230/305, part number (P/N) 9613-1-35-( ), having serial numbers 3241, 3242, 3243, 3244, 3245, 3473, 3474, 3475, 3476, 3481, 3482, 3483, 3484, 3546, 3547, 3548, 3549, 3575, 3576, 3577, 3578, 3591, 3646, 3647, 3648, 3649, 3703, 3958, 3959, 3960, 3961, 4114, 4115, 4116, 4117, 4118, 4119, 4120, 4121, 4122, 4131, 4132, 4133, 4134, 4135, 4175, 4180, 4202, 4203, 4204, 4205, 4206, 4207, 4208, 4209, 4210, 4211, 4212 and 4213, installed on, but not limited to, Airbus Helicopters Deutschland (AHD) Model EC135 and MBB-BK 117 helicopters, Bell Textron Canada Limited Model 429 helicopters, and Bell Textron Inc. Model 412 helicopters. The MCAI states that a determination was made that certain seats that are certified for AF and FF installations have been delivered with an incorrect version of the swivel unit, which has been certified only for AF installation. The FAA is issuing this AD to address an incorrect version of the swivel unit on these medical seats. The unsafe condition, if not addressed, could result in injuries to the occupant during an emergency landing.
FAA's Determination
These products have been approved by the civil aviation authority of another country and are approved for operation in the United States. Pursuant to the FAA's bilateral agreement with this State of Design Authority, that authority has notified the FAA of the unsafe condition described in the MCAI referenced above. The FAA is issuing this AD after determining that the unsafe condition described previously is likely to exist or develop on other products of the same type design.
Material Incorporated by Reference Under 1 CFR Part 51
The FAA reviewed Collins Aerospace Alert Service Bulletin SB 9613-005, Issue D, dated December 3, 2025. This material specifies procedures for modifying the AF certified swivel unit P/N 9715-1 into an FF and AF certified swivel unit P/N 9715-2 and restoring the approved design data and the certified level of safety for the affected variants of the Medical Seats 230/305. This material is reasonably available because the interested parties have access to it through their normal course of business or by the means identified in the
ADDRESSES
section.
AD Requirements
This AD requires either installing a placard on the affected medical seat or modifying and reidentifying of an affected medical seat, which is considered a terminating action for the actions required by this AD.
Justification for Immediate Adoption and Determination of the Effective Date
Section 553(b) of the Administrative Procedure Act (APA) (5 U.S.C. 551et seq.) authorizes agencies to dispense with notice and comment procedures for rules when the agency, for “good cause,” finds that those procedures are “impracticable, unnecessary, or contrary to the public interest.” Under this section, an agency, upon finding good cause, may issue a final rule without providing notice and seeking comment prior to issuance. Further, section 553(d) of the APA authorizes agencies to make rules effective in less than thirty days, upon a finding of good cause.
An unsafe condition exists that requires the immediate adoption of this AD without providing an opportunity for public comments prior to adoption. The FAA has found that the risk to the flying public justifies forgoing notice and comment prior to adoption of this rule. The affected seats that were delivered with an incorrect swivel unit do not meet the approved crashworthiness configuration for forward-facing installations; therefore, the FAA has determined that the corrective action must be accomplished before further flight, in order to prevent injuries to the occupant during an
( printed page 21944)
emergency landing. This compliance time is shorter than the time necessary for the public to comment and for publication of the final rule. Accordingly, notice and opportunity for prior public comment are impracticable and contrary to the public interest pursuant to 5 U.S.C. 553(b).
In addition, the FAA finds that good cause exists pursuant to 5 U.S.C. 553(d) for making this amendment effective in less than 30 days, for the same reasons the FAA found good cause to forgo notice and comment.
Regulatory Flexibility Act
The requirements of the Regulatory Flexibility Act (RFA) do not apply when an agency finds good cause pursuant to 5 U.S.C. 553 to adopt a rule without prior notice and comment. Because FAA has determined that it has good cause to adopt this rule without prior notice and comment, RFA analysis is not required.
Costs of Compliance
The FAA estimates that this AD affects 59 medical seats. The FAA estimates the following costs to comply with this AD:
Estimated Costs
Action
Labor cost
Parts cost
Cost per
product
Cost on U.S.
operators
Modify and reidentify medical seat
1 work-hour × $85 per hour = $85
$25
$110
$6,490
Install a placard on an affected medical seat
1 work-hour × $85 per hour = $85
0
85
5,015
Either the modification or the placard requirement would be required by this AD. The placard would be a minimal parts cost.
The FAA has included all known costs in its cost estimate. According to the manufacturer, however, some of the costs of this AD may be covered under warranty, thereby reducing the cost impact on affected operators.
Authority for This Rulemaking
Title 49 of the United States Code specifies the FAA's authority to issue rules on aviation safety. Subtitle I, section 106, describes the authority of the FAA Administrator. Subtitle VII: Aviation Programs describes in more detail the scope of the Agency's authority.
The FAA is issuing this rulemaking under the authority described in Subtitle VII, Part A, Subpart III, Section 44701: General requirements. Under that section, Congress charges the FAA with promoting safe flight of civil aircraft in air commerce by prescribing regulations for practices, methods, and procedures the Administrator finds necessary for safety in air commerce. This regulation is within the scope of that authority because it addresses an unsafe condition that is likely to exist or develop on products identified in this rulemaking action.
Regulatory Findings
This AD will not have federalism implications under Executive Order 13132. This AD will not have a substantial direct effect on the States, on the relationship between the national government and the States, or on the distribution of power and responsibilities among the various levels of government.
For the reasons discussed above, I certify that this AD:
This airworthiness directive (AD) is effective May 11, 2026.
(b) Affected ADs
None.
(c) Applicability
(1) This AD applies to B/E Aerospace Fischer GmbH (B/E Aerospace Fischer) Medical Seat 230/305 with a part number (P/N) and serial number combination listed in Table 1—affected P/Ns, in Paragraph 1.1 SB [Service Bulletin] Effectivity of Collins Aerospace Alert Service Bulletin (ASB) SB 9613-005, Issue D, dated December 3, 2025 (Collins Aerospace ASB SB 9613-005, Issue D).
(2) These seats are known to be installed on but not limited to: Airbus Helicopters Deutschland (AHD) Model EC135 and MBB-BK 117 helicopters, Bell Textron Canada Limited Model 429 helicopters, and Bell Textron Inc. Model 412 helicopters, certificated in any category.
(d) Subject
Joint Aircraft System Component (JASC) Code 2520, Passenger compartment equipment.
(e) Unsafe Condition
This AD was prompted by a determination that certain medical seats that are certified for aft facing (AF) and forward facing (FF) installations have been delivered with an incorrect version of the swivel unit. The FAA is issuing this AD to address an incorrect version of the swivel unit on these medical seats. The unsafe condition, if not addressed, could result in injuries to the occupant during an emergency landing.
(f) Compliance
Comply with this AD within the compliance times specified, unless already done.
(g) Required Actions
For medical seats identified in paragraph (c) of this AD, before further flight after the effective date of this AD, accomplish one of the following:
(1) Install a placard with the words “Do not occupy” on the affected medical seat; or
(2) Modify each AF certified swivel unit P/N 9715-1 into an FF and AF certified swivel unit P/N 9715-2 in accordance with the Accomplishment Instructions paragraphs 3.1.2 and 3.2 of Collins Aerospace ASB SB 9613-005, Issue D. This modification is considered a terminating action for this AD.
(h) Credit for Previous Actions
This paragraph provides credit for the actions required by paragraph (g)(2) of this AD, if those actions were performed before the effective date of this AD using Collins Aerospace ASB, SB 9613-005, Issue A, dated August 8, 2024; Issue B, dated October 24, 2024; or Issue C, dated November 13, 2024.
( printed page 21945)
(i) Special Flight Permits
Special flight permits may be issued in accordance with 14 CFR 21.197 and 21.199 to operate the helicopter to a location where the actions of this AD can be accomplished, provided an affected medical seat identified in paragraph (c) of this AD is not occupied in the FF configuration.
(j) Alternative Methods of Compliance (AMOCs)
(1) The Manager, International Validation Branch, FAA, has the authority to approve AMOCs for this AD, if requested using the procedures found in 14 CFR 39.19. In accordance with 14 CFR 39.19, send your request to your principal inspector or local Flight Standards District Office, as appropriate. If sending information directly to the manager of the International Validation Branch, send it to the attention of the person identified in paragraph (k)(1) of this AD and email to
AMOC@faa.gov.
(2) Before using any approved AMOC, notify your appropriate principal inspector, or lacking a principal inspector, the manager of the local flight standards district office/certificate holding district office.
(k) Additional Information
(1) For more information about this AD, contact Brenda Buitrago Perez, Aviation Safety Engineer, FAA, 1600 Stewart Avenue, Suite 410, Westbury, NY 11590; phone: (516) 228-7368; email:
9-AVS-AIR-BACO-COS@faa.gov.
(2) Material that is not incorporated by reference can be found at the contact information identified in paragraph (l)(3) of this AD.
(l) Material Incorporated by Reference
(1) The Director of the Federal Register approved the incorporation by reference of the material listed in this paragraph under 5 U.S.C. 552(a) and 1 CFR part 51.
(2) You must use this material as applicable to do the actions required by this AD, unless the AD specifies otherwise.
(i) Collins Aerospace Alert Service Bulletin SB 9613-005, Issue D, dated December 3, 2025.
(ii) [Reserved]
(3) For Collins Aerospace material identified in this AD, contact Collins Aerospace at B/E Aerospace Fischer GmbH Engineering | Helicopter Seating, Mueller-Armack-Str. 4, 84034 Landshut, Germany; phone: +49 871 932 480; email:
info.fischer@collins.com;
website:
collinsaerospace.com.
(4) You may view this material at the FAA, Airworthiness Products Section, Operational Safety Branch, 10101 Hillwood Parkway, Fort Worth, TX 76177. For information on the availability of this material at the FAA, call (817) 222-5110.